Application YC di Humane Genomics

Summer 2021Active

Humane Genomics ha partecipato a Y Combinator nel batch Summer 2021 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Summer 2021
Settore: HealthcareTherapeutics
Dimensione team: 5
Stato: Active
Lanciata: 2021

Founder

Peter WeijmarshausenFounder
Chad MolesFounder

Cosa fa Humane Genomics

Humane Genomics has developed a platform to engineer cancer killing viruses. We have taken a first principles approach to design and make oncolytic viral therapies. Using a highly lytic RNA virus engineered with "2 factor authentication" (using selective infection and selective replication) they have an on-target to off-target kill ratio > 1000. We are working on our first indication, pediatric liver cancer (hepatoblastoma), with our partners at Texas Children's Hospital, who are world leading experts. We have in vivo (mouse) data showing safety and currently developing efficacy data and are showing 50% reduction in tumor volume.

Application YC di Humane Genomics, ricostruita

Domanda per Y Combinator

Humane Genomics, batch Summer 2021. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Humane Genomics

Describe what your company does in 50 characters or less.

Platform to make artificial viruses for cancer

What is your company going to make? Please describe your product and what it does or will do.

We have built a platform that designs and produces oncolytic RNA viruses that selectively kill cancer cells. Our virus uses two independent targeting mechanisms - selective infection and selective replication - to keep healthy cells safe while attacking tumors. Right now, we're applying this tech to pediatric liver cancer and working with Texas Children's Hospital to validate safety and efficacy in animal models.

Where do you live now, and where would the company be based after YC?

We live in New York, NY, and plan to base the company there after YC as well.

Explain your decision regarding location.

We are based in New York because that's where our team is and where we've built our lab and partnerships. It makes sense to stay where we have existing infrastructure and clinical collaborators.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Humane Genomics?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Humane Genomics (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Humane Genomics si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Humane Genomics?

Humane Genomics apparteneva al batch Summer 2021 di Y Combinator.

Chi ha fondato Humane Genomics?

Humane Genomics è stato fondato da Peter Weijmarshausen, Chad Moles.

Cosa fa Humane Genomics?

A platform to make artificial viruses as cancer therapeutics.

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Humane Genomics, e di ogni altro batch YC, è in YC Insights.